1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers
(
- Contribution to journal › Article
-
Mark
Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
(
- Contribution to journal › Article
- 1991
-
Mark
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers
(
- Contribution to journal › Article
-
Mark
No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin
(
- Contribution to journal › Article
- 1990
-
Mark
Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats
(
- Contribution to journal › Article
- 1987
-
Mark
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
(
- Contribution to journal › Article
- 1986
-
Mark
Heparin-induced osteoporosis in rats
(
- Contribution to journal › Article